- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Hypercholesterolemia is most commonly, but not exclusively, defined as elevated levels of low-density lipoprotein cholesterol (LDL-C) or non-high-density lipoprotein cholesterol (HDL-C). Sedentarism and the excessive consumption of saturated fats are considered risk factors. An alternative term used is mixed dyslipidemia, which also includes elevated triglycerides, low levels of HDL-C, and qualitative lipid abnormalities.
Showing all 2 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
PCSK9 |
Monoclonal Antibody |
Praluent® |
150 mg/mL |
– |
6 mg |
tba |
tba |
206,00 € |
||
PCSK9 |
Monoclonal Antibody |
Repatha® |
140 mg/mL |
– |
3,5 mg |
-80 °C |
06/2025 |
135,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin